| |
It will be a 3-hour workshop to be offered by Dr Stephan Ogenstad, Statogen
Consulting, Wake Forest, NC, USA (email: sogenstad@Statogen-Consulting.com) on October 12.
Dose-finding methods aim at coming up with safe and effective drug
administration in humans. One of the fundamental objectives in drug
development is to find a dose, or dose range, of a drug candidate that is
both efficacious and safe in a relative risk-benefit ratio framework.
Dose-finding experiments mark out the safe amount of a drug in development,
in terms of the quantity given to a patient. Statistical methods play a
crucial role in identifying optimal dosage. These methods can provide
reliable results and reduce trial duration and costs. There have been many
advances in this field in recent years. With new statistical techniques
being developed, it is important that these new techniques are utilized
correctly. This workshop reviews the main statistical approaches for
dose-finding in phase I/II clinical trials and presents practical guidance
on their correct use.
|
|